Elevai Labs, Company Insiders
ELAB Stock | 1.25 0.06 5.04% |
Elevai Labs, employs about 18 people. The company is managed by 6 executives with a total tenure of roughly 42 years, averaging almost 7.0 years of service per executive, having 3.0 employees per reported executive. Analysis of Elevai Labs,'s management performance can provide insight into the company performance.
Elevai |
Elevai Labs, Management Team Effectiveness
The company has return on total asset (ROA) of (0.4826) % which means that it has lost $0.4826 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3035) %, meaning that it created substantial loss on money invested by shareholders. Elevai Labs,'s management efficiency ratios could be used to measure how well Elevai Labs, manages its routine affairs as well as how well it operates its assets and liabilities. As of March 2, 2025, Return On Tangible Assets is expected to decline to -0.78. The current year's Return On Capital Employed is expected to grow to -1.03. At present, Elevai Labs,'s Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 1.3 M, whereas Non Current Assets Total are forecasted to decline to about 253.4 K.As of March 2, 2025, Common Stock Shares Outstanding is expected to decline to about 11.6 M
Elevai Labs, Workforce Comparison
Elevai Labs, Common is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 28,415. Elevai Labs, adds roughly 18.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (2.24) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.67) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.67. Elevai Labs, Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevai Labs, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevai Labs,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Elevai Labs, insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Gransee David H over three weeks ago Acquisition by Gransee David H of 4800 shares of Elevai Labs, at 1.05 subject to Rule 16b-3 | ||
Braeden Lichti over a year ago Elevai Labs exotic insider transaction detected | ||
Beuchler Brenda over a year ago Elevai Labs exotic insider transaction detected | ||
Jp Bio Consulting Llc over a year ago Elevai Labs exotic insider transaction detected |
Elevai Labs, Notable Stakeholders
An Elevai Labs, stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Elevai Labs, often face trade-offs trying to please all of them. Elevai Labs,'s stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Elevai Labs,'s stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
FACS FACS | Chief CoFounder | Profile | |
Jordan Plews | President CoFounder | Profile | |
Graydon CFA | Secretary CFO | Profile | |
Christoph Kraneiss | Chief Officer | Profile | |
Brenda Buechler | Chief Officer | Profile | |
Braeden Lichti | Executive Board | Profile |
About Elevai Labs, Management Performance
The success or failure of an entity such as Elevai Labs, Common often depends on how effective the management is. Elevai Labs, management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Elevai management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Elevai management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.75) | (0.78) | |
Return On Capital Employed | (1.08) | (1.03) | |
Return On Assets | (0.75) | (0.78) | |
Return On Equity | (1.29) | (1.23) |
Please note, the presentation of Elevai Labs,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Elevai Labs,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Elevai Labs,'s management manipulating its earnings.
Elevai Labs, Workforce Analysis
Traditionally, organizations such as Elevai Labs, use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Elevai Labs, within its industry.Elevai Labs, Manpower Efficiency
Return on Elevai Labs, Manpower
Revenue Per Employee | 95.1K | |
Revenue Per Executive | 285.4K | |
Net Loss Per Employee | 239K | |
Net Loss Per Executive | 716.9K | |
Working Capital Per Employee | 201.2K | |
Working Capital Per Executive | 603.7K |
Complementary Tools for Elevai Stock analysis
When running Elevai Labs,'s price analysis, check to measure Elevai Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevai Labs, is operating at the current time. Most of Elevai Labs,'s value examination focuses on studying past and present price action to predict the probability of Elevai Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevai Labs,'s price. Additionally, you may evaluate how the addition of Elevai Labs, to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |